about
P2175
Modern extraction techniques and their impact on the pharmacological profile of Serenoa repens extracts for the treatment of lower urinary tract symptomsFinasteride in the treatment of clinical benign prostatic hyperplasia: a systematic review of randomised trials.Apoptotic Pathways Linked to Endocrine System as Potential Therapeutic Targets for Benign Prostatic HyperplasiaThe TURis System for Transurethral Resection of the Prostate: A NICE Medical Technology GuidanceClinical and preclinical treatment of urologic diseases with phosphodiesterase isoenzymes 5 inhibitors: an updateRisk of acute myocardial infarction after transurethral resection of prostate in elderlyTestosterone and benign prostatic hyperplasiaHolmium laser enucleation versus transurethral resection in patients with benign prostate hyperplasia: an updated systematic review with meta-analysis and trial sequential analysisα1-Blockers in Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction: Is Silodosin Different?Intraprostatic Botulinum Neurotoxin Type A Injection for Benign Prostatic Hyperplasia-A Spotlight in RealityOxidative stress in prostate hyperplasia and carcinogenesisThe prevalence of benign prostatic hyperplasia in mainland China: evidence from epidemiological surveysGenetic association between PSA-158G/A polymorphism and the susceptibility of benign prostatic hyperplasia: a meta-analysis.The evolution of KTP laser vaporization of the prostate.Current status of 5alpha-reductase inhibitors in the management of lower urinary tract symptoms and BPH.Silodosin in the treatment of benign prostatic hyperplasiaSafety and efficacy of silodosin for the treatment of benign prostatic hyperplasiaSystematic review and meta-analysis of Transurethral Needle Ablation in symptomatic Benign Prostatic Hyperplasia.Solifenacin/tamsulosin fixed-dose combination therapy to treat lower urinary tract symptoms in patients with benign prostatic hyperplasiaLower urinary tract symptoms in men.Systematic review and meta-analysis of candidate gene association studies of lower urinary tract symptoms in men.Systematic review and meta-analysis on phosphodiesterase 5 inhibitors and α-adrenoceptor antagonists used alone or combined for treatment of LUTS due to BPH.Impact of preoperative 5α-reductase inhibitors on perioperative blood loss in patients with benign prostatic hyperplasia: a meta-analysis of randomized controlled trialsPlasmakinetic resection technology for the treatment of benign prostatic hyperplasia: evidence from a systematic review and meta-analysis.The impact of surgical treatments for lower urinary tract symptoms/benign prostatic hyperplasia on male erectile function: A systematic review and network meta-analysis.Efficacy and safety of prostate artery embolization on lower urinary tract symptoms related to benign prostatic hyperplasia: a systematic review and meta-analysisEfficacy and Safety of Initial Combination Treatment of an Alpha Blocker with an Anticholinergic Medication in Benign Prostatic Hyperplasia Patients with Lower Urinary Tract Symptoms: Updated Meta-Analysis.Diagnostic value of urodynamic bladder outlet obstruction to select patients for transurethral surgery of the prostate: Systematic review and meta-analysisAcupuncture for benign prostatic hyperplasia: A systematic review and meta-analysis.Update on the use of dutasteride in the management of benign prostatic hypertrophy.Doxazosin in the treatment of benign prostatic hypertrophy: an update.Medical therapy options for aging men with benign prostatic hyperplasia: focus on alfuzosin 10 mg once daily.A meta-analysis of the vascular-related safety profile and efficacy of alpha-adrenergic blockers for symptoms related to benign prostatic hyperplasiaToll-like receptors in prostate infection and cancer between bench and bedsideA new algorithm in patients with elevated and/or rising prostate-specific antigen level, minor lower urinary tract symptoms, and negative multisite prostate biopsies.Metabolic syndrome and prostatic disease: potentially role of polyphenols in preventive strategies. A review.Prostate stem cells in the development of benign prostate hyperplasia and prostate cancer: emerging role and concepts.[What role does botulinum toxin play in the treatment of benign prostatic hyperplasia?]Patient centred care for the medical treatment of lower urinary tract symptoms in patients with benign prostatic obstruction: a key point to improve patients' care - a systematic review.Recent advances in managing benign prostatic hyperplasia: The Rezūm System
P921
Q21256691-38C5AB7E-3788-46A9-8036-55ADBB25F94BQ24795452-5F700392-59A0-41E1-86F6-AB0E76342E07Q26741226-D58BCCA2-C7D5-4925-B22F-C831C93995C0Q26773353-DB0CF7FE-715A-47D3-AD1C-9241458B5A1EQ26775925-1E94771B-F057-402B-A51E-0B5819376279Q26859700-F3537018-73BD-4FAB-AA38-AD87F168CEE7Q26863719-27381413-810D-4D37-8425-AA582F7DE332Q26991636-FC4A5EFC-4D3D-4AB3-8D88-C13383137421Q28070342-50457AA2-BEF4-4616-958B-56337F86A6D7Q28075595-DB632F37-2801-4ABA-A43C-60878C44FFB6Q28079474-30D8956A-9A4F-4BA5-AAC6-6F6BEFAB6611Q28082321-2F2D4754-3AE6-49FB-B468-B83F36C23E8BQ30234717-A96752ED-D7CC-457C-B83A-7A3FB406CD8AQ33331428-AD5DA7E9-3BA0-4C62-A2C7-2A266C04405FQ33602452-3C7ECA52-1F91-4249-AE8F-94B448AF8873Q34625490-888E219D-8F34-46B6-A171-9946D193D646Q34630995-7EAFBC5F-E3FF-44BC-8D5A-E880819735D5Q34973367-6BC5590F-0672-4A94-A850-7CDC1DB155C3Q35212816-DE646784-FE9B-4CF3-80BA-0BB90C99B599Q35225398-F99F1A16-612B-4F06-9CF5-F0568DF606ADQ35540054-E519250E-8AF1-4CF7-8D35-7AD91B925685Q35637347-045C9F68-8F40-4BC8-87DE-3D80D327561FQ35649097-A1BDDB7C-8643-4D2F-9A39-0D91C2469D0CQ35686476-423C0ECD-FAF7-44B9-AA2B-C5E0AC603CEFQ36054510-928BAE84-1F2C-4825-909A-9F580716E219Q36221228-C4E6DABA-DF9D-4758-8CB5-20B77F3FD3B3Q36245584-25DFA07B-B9FD-4CA0-9718-79AB19BAAAD7Q36291474-5823EF54-E310-4199-B4B2-8F317EA5F6E8Q36334184-DEB02A60-73FE-4786-A400-67BC415EC57EQ37017292-66700973-2E6E-4259-91B3-4088D9AF44B2Q37018951-C79D603B-7B7F-4343-9C8C-C6FDF5F83009Q37192948-41A42ACC-FE9A-45D6-AD70-46549CB824A8Q37281116-B81081BB-53D1-4A6E-8C73-C9F9D4BA0E66Q37295411-5467891F-C760-4436-9278-01F9926EA9BFQ37507776-23754FE9-8437-4D35-84C2-ED16510E611EQ38861273-08F1D39C-FE9C-43CB-93A4-F21186910DD0Q42154804-17954815-7762-44B3-8C77-42BAECCEFF51Q42327921-39EA2B0D-55C6-4FC7-98E1-891C17DC9885Q55437967-78D48186-2E17-49F7-AA9A-31F9D24BFC67Q60960909-51F97F86-6345-4E89-A440-7694C3D8EF53
P921
description
focal benign glandular hyperplasia in the prostate gland
@en
name
adenoma prostático
@es
adénome de la prostate
@fr
prostatic adenoma
@en
type
label
adenoma prostático
@es
adénome de la prostate
@fr
prostatic adenoma
@en
altLabel
Adenoma of the Prostate
@en
adenoma - prostate
@en
adenoma de próstata
@es
adenoma of prostate
@en
benign adenoma of prostate (disorder)
@en
benign adenoma of prostate
@en
prostate adenoma
@en
prostate gland adenoma
@en
prefLabel
adenoma prostático
@es
adénome de la prostate
@fr
prostatic adenoma
@en
P279
P486
P672
P1692
P1748
P1995
P2176
P279
P2892
P31
P486
P5270
MONDO:0002450
P672
C12.294.565.500